Saturday 17 October 2026 Export HCTI’s income statement to Excel — free account

Healthcare Triangle, Inc.

HCTI Healthcare Health Information Services

Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue grew 158.4%, EPS grew 95.5%, free cash flow grew 67.5% and total debt rose 2,749.9%, each against the same quarter a year earlier.

0.40 0.02 −4.76%

Follow HCTI

Alert me

Market cap: $7.4M
P/E: 0.0×
Fwd P/E: −0.1×
Dividend yield: —
F-score: n/a
Altman Z: −3.33
Beneish M: 0.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 7.40

Revenue 25.68

Net Income (17.02)

Free Cash Flow (17.58)

Net Debt 9.92

Current Ratio 0.60

Debt/Equity 0.24

P/E ratio 0.00

Fwd P/E (0.14)

P/S ratio 0.04

P/B ratio 0.05

Past 5Y EPS Growth —

This Y EPS Growth 77.05%

Next Y EPS Growth 68.91%

Next Y revenue growth 179.61%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 5.41%

10-year low 10-year high

P/B against its own 10 years 0.21%

10-year low 10-year high

EV/Sales against its own 10 years 47.41%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	1	0	8	2
Receivables	4	1	2	6
Inventory	—	—	—	—
Other	1	0	3	2
	6	1	13	10

	2023	2024	2025	Q'26
Payables	2	3	1	1
ST’ Debt	4	3	11	9
Other	2	2	1	5
	8	7	13	16

Compound Annual Growth %

	10y	5y	3y
Sales	—	(15.02%)	(32.85%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	18.10%	(7.06%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	10	9	—	—	—
’25	4	4	3	3	14
’24	4	3	2	2	12
’23	10	9	8	7	33
’22	11	12	12	11	46
’21	8	10	8	9	35
’20	—	8	7	—	31

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	(1)	—	—	—
’25	(6)	(3)	(1)	(7)	(17)
’24	0	(1)	1	(1)	(1)
’23	(2)	(1)	0	1	(2)
’22	0	0	(1)	(2)	(3)
’21	(2)	(1)	0	(3)	(7)
’20	—	—	(2)	1	(1)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	(1)	—	—	—
’25	(6)	(3)	(3)	(7)	(18)
’24	0	(1)	1	(1)	(1)
’23	(2)	(1)	0	1	(2)
’22	0	(2)	(2)	(2)	(6)
’21	(2)	(1)	0	(6)	(10)
’20	—	—	(2)	1	(1)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(6.81)	(1.56)	—	—	—
’25	(2.54k)	(34.73)	(25.15)	2.49k	(152.30)
’24	(6.29k)	(4.19k)	(3.29k)	(3.44k)	(16.92k)
’23	(11.98k)	(6.29k)	(6.89k)	(6.30k)	(31.12k)
’22	(0.06)	(1.71k)	(10.48k)	(19.46k)	(38.92k)
’21	(0.03)	0.01	(0.07)	(0.12)	(0.20)
’20	—	0.00	0.01	—	0.08

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	233,064.00	16,583.40	25,696.80	4,332.60	36.00	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	649,890.00	286,848.00	162,696.59	63,345.60	26,145.00
People
People	Employees	—	—	—	—	69	77	51	33	36	84
	Revenue/emp, $m	—	—	—	0.00	0.45	0.46	0.90	1.01	0.32	0.17
Income, $m
Income, $m	Revenue	—	—	—	29	31	35	46	33	12	14
	Gross margin, %	—	—	—	20.35	27.40	29.83	24.62	20.41	24.71	13.61
	EBT	—	—	—	2	3	(6)	(10)	(9)	(6)	(9)
	EBT margin, %	—	—	—	5.63	8.33	(16.80)	(20.81)	(26.05)	(50.93)	(68.22)
	Net income	—	0	—	1	2	(6)	(10)	(9)	(6)	(9)
	Depreciation	—	—	—	1	1	1	3	2	2	1
Per share, $
Per share, $	Revenue	—	—	—	8.17	1.12	1.20	229,430.00	110,676.67	29,240.00	224.41
	Earnings	—	—	—	0.33	0.08	(0.20)	(38,922.15)	(31,115.08)	(16,916.17)	(152.30)
	Cash flow	—	—	—	1.13	(0.03)	(0.24)	(13,000.00)	(7,170.00)	(2,702.50)	(266.93)
	Capex	—	—	—	(1.04)	(0.02)	(0.11)	(16,595.00)	(40.00)	0.00	(24.30)
	Free cash flow	—	—	—	0.09	(0.04)	(0.35)	(29,595.00)	(7,210.00)	(2,702.50)	(291.23)
	Book value	—	—	—	0.56	0.16	0.55	61,940.00	(4,636.67)	(12,785.00)	160.65
	Shares, m	—	—	—	4	28	29	0	0	0	0
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	462,544.22	462,544.22	225,623.57	0.12	0.39	0.50	0.17
	P/B	—	—	—	5,712,467.18	5,712,467.18	493,197.59	0.46	0.00	0.00	0.94
	EV/Sales	—	—	—	462,544.24	462,544.24	225,623.58	0.15	0.47	0.80	0.46
	EV/FCF	—	—	—	(5,812,716.34)	(5,812,716.34)	(1,103,770.48)	(0.75)	(2.84)	(3.97)	(0.35)
Cash, $m
Cash, $m	Operating cash flow	—	—	—	4	(1)	(7)	(3)	(2)	(1)	(17)
	Capex	—	—	—	(4)	0	(3)	(3)	0	—	(2)
	Free cash flow	—	—	—	0	(1)	(10)	(6)	(2)	(1)	(18)
Balance, $m
Balance, $m	Working capital	—	—	—	(1)	1	6	2	(2)	(6)	0
	Total debt	—	—	—	—	1	2	2	4	3	11
	Net debt	—	—	—	(1)	(1)	0	1	3	3	3
	Shareholders’ equity	—	—	—	2	4	16	12	(1)	(5)	10
Returns, %
Returns, %	ROA	—	—	—	28.41	24.31	(33.31)	(42.36)	(62.89)	(135.37)	(76.74)
	ROIC	—	—	—	104.31	19.98	(20.20)	(48.37)	(381.70)	0.00	(46.86)
	ROE	—	—	—	37.19	74.67	(58.14)	(67.38)	(157.97)	85.64	188.76

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
RNLXY Renalytix plc - Sponsored ADR	$17.2M	— (loss-making)	—	+13.73% (above 0%: growing)	n/m	+17.96% (above 0%: growing)	19.16%	(783.91%)	Compare
BFRG Bullfrog AI Holdings Inc.	$9.9M	— (loss-making)	—	+2,054.00% (above 0%: growing)	n/m	−5.67% (below 0%: shrinking)	49.63%	(658.82%)	Compare
ETAOF ETAO International Co., Ltd.	$9.8M	— (loss-making)	—	—	n/m	+37,595.70% (above 0%: growing)	—	0.00%	Compare
HCTI Healthcare Triangle, Inc.	$7.4M	0.0×	— (loss-making)	+158.38% (above 0%: growing)	n/m	+67.48% (above 0%: growing)	22.48%	(44.28%)
MGRX Mangoceuticals, Inc.	$7.1M	— (loss-making)	—	−59.07% (below 0%: shrinking)	n/m	+79.27% (above 0%: growing)	64.24%	(1,501.45%)	Compare
HLTHQ Cue Health Inc.	$6.9M	— (loss-making)	— (loss-making)	−87.19% (below 0%: shrinking)	n/m	+50.55% (above 0%: growing)	(90.14%)	(792.13%)	Compare
ZCMD Zhongchao Inc.	$6.2M	— (loss-making)	—	+20.44% (above 0%: growing)	−550.00% (below 0%: shrinking)	+191.85% (above 0%: growing)	41.67%	0.00%	Compare
ACON Aclarion, Inc.	$5.6M	— (loss-making)	— (loss-making)	+30.57% (above 0%: growing)	n/m	−41.41% (below 0%: shrinking)	32.94%	(11,506.75%)	Compare
VSEED VSee Health, Inc.	$2.8M	— (loss-making)	— (loss-making)	+48.02% (above 0%: growing)	n/m	−257.62% (below 0%: shrinking)	13.20%	(172.69%)	Compare
Median of peers	$7.0M	—	—	+20.44%	—	+34.25%	32.94%	(721.36%)

All 51 Health Information Services stocks →

Healthcare Triangle, Inc. (HCTI) key facts

Strength: Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024.
Healthcare Triangle, Inc. (HCTI) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, HCTI traded at $0.40, a market capitalization of $7.4 million.
Return on equity was 188.8% and debt-to-equity 0.24.
Its Altman Z-score is −3.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.